003 IR Dashboard

Get considerable insight
into the William Demant
share and financial status




Please go to Calendar & Presentations, if you wish to see the latest IR presentation

23 February Copenhagen (SEB)
26 February London (Danske Bank)
27 February London (Morgan Stanley European MedTech & Services Conference)
27 February Paris (Nordea)
28 February Franfurt (Commerzbank)
28 February Edinburgh (Handelsbanken)
1 March Zurich (Crédit Suisse)
1 March Dublin (DnB)
2 March Geneva (Bank of America Merrill Lynch)
6 March Brussels (Danske Bank)
6-7 March New York (Carnegie)
7 March The Netherlands (Danske Bank)
8 March Boston (Deutsche Bank)
8 March Oslo (Nordea)
15 March Lugano (Kepler Cheuvreux)
15 March Stockholm (Carnegie Healthcare Seminar)
16 March Milan (Kepler Cheuvreux)
16-17 April New York (UBS)
17 April Montreal (Mirabaud)
18 April Toronto (Mirabaud)
18 April Chicago (Exane BNP Paribas)

Document library

Download and browse reports, presentations and documents within the areas Annual General Meeting, Investor Relations, Responsibility, Corporate Governance and Business policies.

File List


+13% Arrow-ir

2016: DKK 12,002 million

2015: DKK 10,665 million

Operating profit (EBIT adjusted)

+12% Arrow-ir

2016: DKK 2,130 million

2015: DKK 1,902 million

latest annual report

Fact box - 1920x500

leading in hearing healthcare

The William Demant Group is one of the world’s leading hearing healthcare companies. We are in the business of making a life-changing difference for millions of people across the world.

We are the only company in the world that covers all the four business activities of the hearing healthcare area, i.e. traditional hearing instruments, hearing implants, diagnostic instruments as well as personal communication.

With our approach to hearing healthcare and our complete product range, we are fully equipped to help people with various kinds of hearing loss connect with the world and live their lives to the fullest.